Thus, for GBM specifically, this decreases the importance of trends identified on the upper ranges for the tumor growth rate, T cell kill rate, and the inhibition rates by PD-L1-PD-1 and by MDSCs, and increases the importance of the MDSC death rate as a marker of long-term treatment failure or success. This evidence concerns the gene CD274 and glioblastoma.